Literature DB >> 23975880

On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors.

Mari Hansson1, John Pemberton2, Ola Engkvist3, Isabella Feierberg3, Lars Brive4, Philip Jarvis2, Linda Zander-Balderud3, Hongming Chen5.   

Abstract

High-throughput screening (HTS) is widely used in the pharmaceutical industry to identify novel chemical starting points for drug discovery projects. The current study focuses on the relationship between molecular hit rate in recent in-house HTS and four common molecular descriptors: lipophilicity (ClogP), size (heavy atom count, HEV), fraction of sp(3)-hybridized carbons (Fsp3), and fraction of molecular framework (f(MF)). The molecular hit rate is defined as the fraction of times the molecule has been assigned as active in the HTS campaigns where it has been screened. Beta-binomial statistical models were built to model the molecular hit rate as a function of these descriptors. The advantage of the beta-binomial statistical models is that the correlation between the descriptors is taken into account. Higher degree polynomial terms of the descriptors were also added into the beta-binomial statistic model to improve the model quality. The relative influence of different molecular descriptors on molecular hit rate has been estimated, taking into account that the descriptors are correlated to each other through applying beta-binomial statistical modeling. The results show that ClogP has the largest influence on the molecular hit rate, followed by Fsp3 and HEV. f(MF) has only a minor influence besides its correlation with the other molecular descriptors.
© 2013 Society for Laboratory Automation and Screening.

Entities:  

Keywords:  HTS; beta-binomial statistics; promiscuity

Mesh:

Substances:

Year:  2013        PMID: 23975880     DOI: 10.1177/1087057113499631

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  2 in total

Review 1.  Evaluating and evolving a screening library in academia: the St Jude approach.

Authors:  Gisele Nishiguchi; Sourav Das; Jason Ochoada; Heather Long; Richard E Lee; Zoran Rankovic; Anang A Shelat
Journal:  Drug Discov Today       Date:  2021-01-14       Impact factor: 7.851

2.  Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza.

Authors:  Claire Scott; Jayakanth Kankanala; Toshana L Foster; Daniel H Goldhill; Peng Bao; Katie Simmons; Marieke Pingen; Matthew Bentham; Elizabeth Atkins; Eleni Loundras; Ruth Elderfield; Jolyon K Claridge; Joseph Thompson; Peter R Stilwell; Ranjitha Tathineni; Clive S McKimmie; Paul Targett-Adams; Jason R Schnell; Graham P Cook; Stephen Evans; Wendy S Barclay; Richard Foster; Stephen Griffin
Journal:  PLoS Pathog       Date:  2020-08-11       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.